380 / 412
8. Yamaoka Y, ed.
Helicobacter pylori: Molecular Genetics and Cellular Biology.
Nor-
wich, England: Caister Academic Press; 2008.
9. Oridate N, Takeda H, Yamamoto J, et al.
Helicobacter pylori
seropositivity pre-
dicts outcomes of acid suppression therapy for laryngopharyngeal reflux
symptoms.
Laryngoscope
. 2006;116(4):547-553.
10. Tezer MS, Kockar MC, Koc¸kar O, Celik A. Laryngopharyngeal reflux finding scores
correlate with gastroesophageal reflux disease and
Helicobacter pylori
expression.
Acta Otolaryngol
. 2006;126(9):958-961.
11. Gulcan EM, Varol A, Kutlu T, et al.
Helicobacter pylori
stool antigen test.
Indian
J Pediatr
. 2005;72(8):675-678.
12. Oderda G, Rapa A, Ronchi B, et al. Detection of
Helicobacter pylori
in stool speci-
mens by non-invasive antigen enzyme immunoassay in children: multicentre Ital-
ian study.
BMJ
. 2000;320(7231):347-348.
13. Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in
the management of acid-related disorders.
Drugs
. 2002;62(10):1503-1538.
14. Ni YH, Lin JT, Huang SF, Yang JC, Chang MH. Accurate diagnosis of
Helicobac-
ter pylori
infection by stool antigen test and 6 other currently available tests in
children.
J Pediatr
. 2000;136(6):823-827.
15. Barry DW, Vaezi MF. Laryngopharyngeal reflux: more questions than answers.
Cleve Clin J Med
. 2010;77(5):327-334.
16. Thomson ABR, Barkun AN, Armstrong D, et al. The prevalence of clinically sig-
nificant endoscopic findings in primary care patients with uninvestigated dys-
pepsia: the Canadian Adult Dyspepsia Empiric Treatment–Prompt Endoscopy
(CADET-PE) study.
Aliment Pharmacol Ther
. 2003;17(12):1481-1491.
17. Issing WJ, Karkos PD, Perreas K, Folwaczny C, Reichel O. Dual-probe 24-hour
ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux.
J Laryn-
gol Otol
. 2004;118(11):845-848.
18. Ahmad I, Batch AJ. Acid reflux management: ENT perspective.
J Laryngol Otol
.
2004;118(1):25-30.
19. Pinar E, Oncel IS, Calli C, Atalay M. Detection of gastroesophageal reflux by scin-
tigraphy in patients with laryngopharyngeal symptoms and findings [in Turkish].
Kulak Burun Bogaz Ihtis Derg
. 2003;10(4):153-158.
20. Yorulmaz I, Ozlugedik S, Kucuk B. Gastroesophageal reflux disease: symptoms
versus pH monitoring results.
Otolaryngol Head Neck Surg
. 2003;129(5):582-
586.
21. Haruma K, Hamada H, Mihara M, et al. Negative association between
H. pylori
infection and reflux esophagitis in older patients: case-control study in Japan.
Helicobacter
. 2000;5(1):24-29.
22. Rouev P, Chakarski I, Doskov D, Dimov G, Staykova E. Laryngopharyngeal symp-
toms and gastroesophageal reflux disease.
J Voice
. 2005;19(3):476-480.
23. Tauber S, Gross M, Issing WJ. Association of laryngopharyngeal symptoms with
gastroesophageal reflux disease.
Laryngoscope
. 2002;112(5):879-886.
24. Ercan I, Cakir BO, Uzel TS, Sakiz D, Karaca C, Turgut S. The role of gastric Heli-
cobacter pylori infection in laryngopharyngeal reflux disease.
Otolaryngol Head
Neck Surg
. 2006;135(1):52-55.
25. Postma GN, Johnson LF, Koufman JA. Treatment of laryngopharyngeal reflux.
Ear Nose Throat J
. 2002;81(9)(suppl 2):24-26.
26. Ching SS, Sabanathan S, Jenkinson LR. Treatment of Helicobacter pylori in sur-
gical practice: a randomised trial of triple versus quadruple therapy in a rural dis-
trict general hospital.
World J Gastroenterol
. 2008;14(24):3855-3860.
(REPRINTED) ARCH OTOLARYNGOL HEAD NECK SURG/VOL 136 (NO. 11), NOV 2010
WWW.ARCHOTO.COM155